Ibsan
Generic Name
Hypothetical Active Ingredient 150 mg
Manufacturer
Hypothetical Pharma Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
Variant | Unit Price | Strip Price |
---|---|---|
ibsan 150 mg tablet | ৳ 10.00 | N/A |
Description
Overview of the medicine
Ibsan 150 mg Tablet contains a hypothetical active ingredient primarily used for pain relief and reducing inflammation. It belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs) or a similar therapeutic group, providing symptomatic relief for various conditions.
Uses & Indications
Dosage
Adults
The usual adult dose is 150 mg once or twice daily, preferably with food. Max dose 300 mg/day.
Elderly
Lower doses may be required; caution is advised due to increased risk of side effects. Consult a doctor.
Renal_impairment
Dosage adjustment may be necessary in patients with severe renal impairment. Consult a doctor.
How to Take
Take the tablet whole with a glass of water, preferably with or after food to minimize gastrointestinal discomfort.
Mechanism of Action
The active ingredient in Ibsan 150 mg works by inhibiting the activity of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2. This inhibition leads to a reduction in the synthesis of prostaglandins, which are mediators of pain, inflammation, and fever.
Pharmacokinetics
Onset
Within 30-60 minutes.
Excretion
Mainly excreted in the urine as metabolites, with a small portion excreted in feces.
Half life
Approximately 2-4 hours.
Absorption
Rapidly and almost completely absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 1-2 hours.
Metabolism
Primarily metabolized in the liver by oxidation and conjugation.
Side Effects
Contraindications
- Known hypersensitivity to the active ingredient or other NSAIDs (e.g., aspirin)
- Active gastrointestinal bleeding or peptic ulcer
- Severe heart failure, renal failure, or hepatic failure
- Third trimester of pregnancy
Drug Interactions
Corticosteroids
Increased risk of gastrointestinal ulceration and bleeding.
Lithium and Methotrexate
Increased plasma levels of these drugs, leading to toxicity.
Diuretics and ACE inhibitors
Reduced efficacy of these drugs; increased risk of renal impairment.
Anticoagulants (e.g., Warfarin)
Increased risk of bleeding.
Storage
Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
Overdose
Symptoms of overdose may include nausea, vomiting, abdominal pain, drowsiness, and headache. Severe overdose may lead to gastrointestinal bleeding, acute renal failure, and respiratory depression. Treatment is symptomatic and supportive, including gastric lavage and activated charcoal if recent ingestion.
Pregnancy & Lactation
Not recommended during the third trimester of pregnancy due to potential fetal harm. Use during the first and second trimesters and during lactation only if the potential benefit outweighs the potential risk. Consult a doctor.
Side Effects
Contraindications
- Known hypersensitivity to the active ingredient or other NSAIDs (e.g., aspirin)
- Active gastrointestinal bleeding or peptic ulcer
- Severe heart failure, renal failure, or hepatic failure
- Third trimester of pregnancy
Drug Interactions
Corticosteroids
Increased risk of gastrointestinal ulceration and bleeding.
Lithium and Methotrexate
Increased plasma levels of these drugs, leading to toxicity.
Diuretics and ACE inhibitors
Reduced efficacy of these drugs; increased risk of renal impairment.
Anticoagulants (e.g., Warfarin)
Increased risk of bleeding.
Storage
Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
Overdose
Symptoms of overdose may include nausea, vomiting, abdominal pain, drowsiness, and headache. Severe overdose may lead to gastrointestinal bleeding, acute renal failure, and respiratory depression. Treatment is symptomatic and supportive, including gastric lavage and activated charcoal if recent ingestion.
Pregnancy & Lactation
Not recommended during the third trimester of pregnancy due to potential fetal harm. Use during the first and second trimesters and during lactation only if the potential benefit outweighs the potential risk. Consult a doctor.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
24 months from the date of manufacture.
Availability
Pharmacies, Hospitals
Approval Status
Approved for use
Patent Status
Generic available
Clinical Trials
Clinical trial data supporting the efficacy and safety of the active ingredient are available and consistent with other drugs in its class. Specific trials for the Ibsan brand are proprietary.
Lab Monitoring
- Monitor complete blood count (CBC) regularly, especially with long-term use.
- Monitor renal function (creatinine, BUN) periodically.
- Monitor liver function tests (ALT, AST) periodically.
Doctor Notes
- Assess cardiovascular and gastrointestinal risk factors before prescribing, especially for long-term therapy.
- Advise patients to report any signs of GI bleeding or severe abdominal pain promptly.
- Monitor renal function and blood pressure, particularly in elderly or renally impaired patients.
Patient Guidelines
- Do not exceed the recommended dose.
- Take with food or milk to minimize stomach upset.
- Inform your doctor about all other medications you are taking.
Missed Dose Advice
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Driving Precautions
Ibsan 150 mg may cause dizziness or drowsiness in some individuals. If you experience these effects, avoid driving or operating machinery.
Lifestyle Advice
- Maintain adequate hydration.
- Avoid or limit alcohol consumption during treatment.
- Avoid smoking.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine. Click a brand to search for detailed information.
Other Medicines in Ibsan Brand
Other medicines available under the same brand name